237 related articles for article (PubMed ID: 34389380)
61. Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.
Cao J; Liu Y; Zhou M; Dong S; Hou Y; Jia X; Lan X; Zhang Y; Guo J; Xiao G; Wang W
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215943
[TBL] [Abstract][Full Text] [Related]
62. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
63. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.
Colpitts CC; Schang LM
J Virol; 2014 Jul; 88(14):7806-17. PubMed ID: 24789779
[TBL] [Abstract][Full Text] [Related]
64. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Ibrahim IM; Elfiky AA; Elgohary AM
Biochem Biophys Res Commun; 2021 Jul; 562():89-93. PubMed ID: 34049205
[TBL] [Abstract][Full Text] [Related]
65. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
[TBL] [Abstract][Full Text] [Related]
66. Antiviral effect of epigallocatechin gallate on enterovirus 71.
Ho HY; Cheng ML; Weng SF; Leu YL; Chiu DT
J Agric Food Chem; 2009 Jul; 57(14):6140-7. PubMed ID: 19537794
[TBL] [Abstract][Full Text] [Related]
67. Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
Bhat R; Adam AT; Lee JJ; Deloison G; Rouillé Y; Séron K; Rotella DP
Bioorg Med Chem Lett; 2014 Sep; 24(17):4162-5. PubMed ID: 25103601
[TBL] [Abstract][Full Text] [Related]
68. Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.
Aarthy M; Panwar U; Singh SK
Sci Rep; 2020 May; 10(1):8661. PubMed ID: 32457393
[TBL] [Abstract][Full Text] [Related]
69. Dual action of epigallocatechin-3-gallate in virus-induced cell Injury.
Mostafa A; Mostafa-Hedeab G; Elhady HA; Mohamed EA; Eledrdery AY; Alruwaili SH; Al-Abd AM; Allayeh AK
J Genet Eng Biotechnol; 2023 Nov; 21(1):145. PubMed ID: 38012348
[TBL] [Abstract][Full Text] [Related]
70. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.
Zhang Z; Zhang X; Bi K; He Y; Yan W; Yang CS; Zhang J
Trends Food Sci Technol; 2021 Aug; 114():11-24. PubMed ID: 34054222
[TBL] [Abstract][Full Text] [Related]
71. Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID.
Frank N; Dickinson D; Garcia W; Liu Y; Yu H; Cai J; Patel S; Yao B; Jiang X; Hsu S
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399972
[TBL] [Abstract][Full Text] [Related]
72. Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19.
Man GCW; Zheng X; Hung SW; Chan LKY; Zhang T; Chen X; Chu KO; Huen ICY; Lui DWY; Wong AD; Wang CC
Curr Top Med Chem; 2024; 24(1):60-73. PubMed ID: 38291871
[TBL] [Abstract][Full Text] [Related]
73. Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases.
Park J; Park R; Jang M; Park YI
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33806274
[TBL] [Abstract][Full Text] [Related]
74. Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study.
Alavi M; Mozafari MR; Ghaemi S; Ashengroph M; Hasanzadeh Davarani F; Mohammadabadi M
Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551830
[TBL] [Abstract][Full Text] [Related]
75. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor.
Liu J; Bodnar BH; Meng F; Khan AI; Wang X; Saribas S; Wang T; Lohani SC; Wang P; Wei Z; Luo J; Zhou L; Wu J; Luo G; Li Q; Hu W; Ho W
Cell Biosci; 2021 Aug; 11(1):168. PubMed ID: 34461999
[TBL] [Abstract][Full Text] [Related]
76. Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins.
Takeda Y; Tamura K; Jamsransuren D; Matsuda S; Ogawa H
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443390
[TBL] [Abstract][Full Text] [Related]
77. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
Zhang D; Hamdoun S; Chen R; Yang L; Ip CK; Qu Y; Li R; Jiang H; Yang Z; Chung SK; Liu L; Wong VKW
Pharmacol Res; 2021 Oct; 172():105820. PubMed ID: 34403732
[TBL] [Abstract][Full Text] [Related]
78. Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection.
Cheng FJ; Huynh TK; Yang CS; Hu DW; Shen YC; Tu CY; Wu YC; Tang CH; Huang WC; Chen Y; Ho CY
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444960
[TBL] [Abstract][Full Text] [Related]
79. An update of anti-viral treatment of COVID-19.
Şimşek-Yavuz S; Komsuoğlu Çelikyurt FI
Turk J Med Sci; 2021 Dec; 51(SI-1):3372-3390. PubMed ID: 34391321
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
